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Summary 
Mice with a targeted disruption of the interferon 7 receptor gene (IFN-TK  ~176  mice) and control 
wild-type mice were inoculated with the Bacillus Calmette-Gu6rin (BCG) strain of Mycobacteriura 
boris. BCG infection was not lethal for wild-type mice whereas all IFN-7  K~176  mice died ,07-9 
wk after inoculation.  Histological  examination  at 2 and 6 wk after BCG inoculation showed 
that livers of IFN-TK  ~176  mice had higher numbers of acid-fast bacteria than wild-type mice, 
especially at 6 wk. In parallel, the livers of IFN-TR  ~176  mice showed a reduction in the formation 
of characteristic granulomas at 2 wk after inoculation. Injection of lipopolysaccharide (LPS) 2 wk 
after BCG inoculation was significantly less lethal for IFN-TK  ~176  mice than for wild-type mice. 
Reduced lethality of LPS correlated with a drastically reduced production of tumor necrosis factor 
c~ (TNF-cr  in the IFN-TR  ~176  mice. Interleukin lot (IL-lot)  and IL-6 levels in the serum were 
also significantly reduced in the IFN-7  K~176  mice after BCG infection and LPS challenge. The 
greatly reduced capacity  of BCG-infected  IFN-TK  ~176  mice to  produce TNF-ot  may be  an 
important factor in their inability to resist BCG infection. These results show that the presence 
of a functional IFN-7 receptor is essential for the recovery of mice from BCG infection,  and 
that IFN-7 is a key element in the complex process  whereby  BCG infection leads to the sensitization 
to endotoxin. 
E 
xperimental infection of mice with the avirulent Bacillus 
Calmette-Gu~rin (BCG) vaccine strain of Mycobacteriurn 
bovis represents a well-established model for the study of cel- 
lular immune responses. Among the alterations in immune 
responses seen in mice with BCG infection are increased re- 
sistance to homologous and heterologous intracellular infec- 
tious agents (1, 2), enhanced resistance  to transplantable  tumors 
(3), increased production of a number of cytokines including 
TNF-ot (4), IFN-c~/~ (5), and IFN-7 (6), and greatly in- 
creased sensitivity to the lethal action of LPS (7). Although 
mouse strains differ in the degree of resistance to BCG infec- 
tion (8, 9), even genetically susceptible mice that develop ex- 
tensive granulomatous inflammatory lesions in their livers, 
spleens, and lungs survive infection with high doses of BCG. 
The numbers of viable bacteria recovered from the livers and 
spleens of BCG-infected mice reach a peak at 2-3 wk after 
inoculation and then gradually decline (1,  10). 
Kindler et al. (11) demonstrated the importance of TNF 
in the recovery of genetically susceptible mice from BCG in- 
fection.  Administration of Abs against murine TNF-c~ to 
BCG-infected mice led to a marked increase in the number 
of mycobacteria present in their livers. The altered course of 
infection correlated with a defect in the formation of  bacteri- 
cidal granulomas  within the livers. The authors  concluded 
that local production of TNF-a within the granulomas was 
essential for the elimination of mycobacteria and recovery of 
mice from BCG infection.  A beneficial role for TNF was 
also demonstrated in experimental infections of mice with 
M. avium and M. tuberculosis (12, 13). These studies have es- 
tablished a dear role for TNF-c~ in host resistance to mycobac- 
terial infections. 
The role of IFN-7 in host resistance to BCG and related 
mycobacterial infections  is  less clearly established.  It was 
reported that  the administration  of IFN-7  decreased the 
number ofmycobacteria  recovered from the spleens of  BCG- 
infected euthymic mice, whereas it apparently exacerbated 
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reported that IFN-3/was unable to stimulate bactericidal ac- 
tivity against M. avium or M. tuberculosis in human mono- 
cytes or murine macrophages (15-17), whereas others were 
successful in demonstrating a decreased mycobacterial growth 
(18) or increased mycobactericidal activity (19). The adminis- 
tration of IFN-3' was ineffective in the experimental murine 
infection with M. avium  (17),  whereas a beneficial role for 
IFN-3/was found in the experimental infection of mice with 
M. tuberculosis (13). The generation of mice with a homozy- 
gous targeted disruption of the IFN-y receptor gene (20) has 
made it possible to critically determine the role of the IFN-'y 
receptor in the resistance of mice to BCG infection and in 
some manifestations of immune responses characteristic for 
BCG infection. 
Materials and Methods 
Animals and Reagents.  Mice with a deletion in the gene coding 
for the IFN-3, receptor have been generated as previously reported 
(20).  Homozygous  IFN-~/R  ~176  or  wild-type  (129/SWEV  x 
C57BL/6)F2 or (129/SWEV  x  129/SV/EV)F2 mice aged between 
2 and 10 mo, were used in the experiments.  ELISA kits for the 
determination  of routine TNF-ce and murine Ib6 were purchased 
from Endogen Inc. (Boston, MA) and ELISA kits for murine Ib 
lce were from Genzyme Corp.  (Cambridge,  MA). 
BCG and LPS Inoculation.  BCG was from Connaught Labora- 
tories Inc. (Swiftwater, PA). Freeze-dried live bacteria were recon- 
stituted with PBS supplemented with 0.025% Tween 80. Mice were 
inoculated in the tail vein with 0.2 ml of a bacterial suspension 
containing  2  x  107 viable cells. At 2 wk after inoculation  with 
BCG, some of the BCG-infected as well as uninoculated mice were 
injected in the tail vein with 25 #g of LPS from Escherichia coli 
0127:B8 (Sigma Chemical Co., St. Louis, MO). For determination 
of serum cytokine levels, BCG- and/or LPS-injected mice were bled 
at 2 h after LPS injection, blood was allowed to clot at room tem- 
perature, and serum was collected after centrifugation  and stored 
at  -70~  until cytokine assay. Serum levels of TNF, IL-lc~, and 
Ib6 were measured by ELISA. 
Histology.  Mice were killed 2 and 6 wk after BCG inoculation. 
Livers, lungs, and spleens were harvested and fixed with 10% for- 
malin. Sections (5/~m) from paraffin blocks containing these organs 
were cut and stained with hematoxylin and eosin. Randomly selected 
(n  =  20) high-power fields (x400) of liver sections from each an- 
imal were examined for the presence of granulomas with the aid 
of a computerized digitizing tablet. In addition, 5-/~m thick paraffin 
sections of the liver were stained with the Ziehl-Neelsen acid fast 
stain, and counterstained  with Light green.  Acid-fast rods were 
quantitated  by microscopic examination in randomly  selected (n 
= 20) high-power fields (x400) of liver sections from each animal. 
Results 
Infection with BCG is Lethal for IFN-TR ~176  Mice.  Inocu- 
lation of normal mice with the attenuated BCG vaccine strain 
of M.  boris leads to a nonlethal,  stir-limiting  infection  (1, 
8,  11). To determine the effects of BCG infection in mice 
lacking  the IFN-3' receptor,  five IFN-3,R  ~176  mice and five 
wild-type mice were inoculated intravenously with BCG (2 
x  107 live bacteria per mouse). All IFNwR  ~176  mice died be- 
tween 49 and 65 d after BCG inoculation, whereas all wild- 
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type mice survived for at least 180 d (data not shown). Histo- 
logical examination of the IFN-3~R  ~176  mice showed massive 
granulomatous pulmonary lesions that were the probable cause 
of death.  The observation that BCG infection is uniformly 
lethal in mice lacking IFN-~/receptors extends the recently 
reported finding  that  mice with  a targeted deletion of the 
structural  gene for IFN-3, fail to recover from BCG infec- 
tion  (21). 
Altered Granuloma Formation and Increased Number of Acid- 
fast Bacteria in the Livers of lFN-'yR o/~ Mice after BCG Infec- 
tion.  Wild-type and IFN-3,R  ~176  mice infected with BCG 
had granulomatous inflammatory lesions in the liver, spleen, 
and lungs at 2 and 6 wk after infection, which occurred in 
a morphological pattern similar to that of miliary tubercu- 
lofts. The liver lesions were more weU-demarcated from normal 
tissue than the lesions in spleen and lungs, and the livers were 
therefore used for qualitative and quantitative assessment of 
the granulomatous reaction to BCG infection and evaluation 
of  the  presence  of  mycobacteria.  The  area  occupied  by 
granulomatous lesions at 2 wk after infection was 62% less 
in  liver  sections from  IFN-3,R  ~176  mice than  in  wild-type 
mice (Table  1). A  strong reduction in the area occupied by 
lesions occurred in wild-type mice between 2 and 6 wk after 
infection. In contrast, IFN-3,R  ~176  mice showed, if anything, 
a slight increase in the percent area occupied by lesions over 
this time period.  The  granulomas  contained  acid-fast bac- 
teria,  often inside macrophages  (Fig.  1 e).  The number  of 
acid-fast bacteria present in the liver sections was greater in 
IFN-3,R  ~176  mice than in wild-type mice. This difference was 
significant at 2 wk after infection and highly significant at 
6 wk (Table  1). In wild-type mice the number of acid-fast 
bacteria in the liver was considerably lower at 6 than at 2 wk. 
The decrease in the number of acid-fast bacteria over this time 
period was much less pronounced in IFN-'yR  ~176  mice. 
At 2 wk after BCG inoculation the livers of wild-type mice 
contained numerous randomly distributed small granuloma- 
tous inflammatory areas that were poorly demarcated. These 
granulomas consisted of macrophages and epithelioid cells, 
as well as some fibroblasts and occasional lymphocytes, cen- 
tral necrosis was infrequent, and there were no muhinucleated 
(Langerhans) cells (Fig.  I a). In contrast to wild-type mice, 
IFN-~/R  ~176  mice had well-demarcated lesions that were dis- 
tinctly more cellular,  in part because there appeared to be 
fewer epithelioid cells, and in part because there were, unlike 
in the wild-type mice, variable numbers of neutrophils and 
occasional eosinophils  (Fig.  1 b). 
At 6 wk after BCG inoculation, wild-type mice had dis- 
tinctly smaller, fewer, and more well-demarcated granuloma- 
tous lesions in their livers than at 2 wk. In addition to mac- 
rophages, epithelioid ceUs, and some fibroblasts, the lesions 
contained more lymphocytes at 6 than at 2 wk, and frequently 
had some central necrosis, and occasionally a Langerhans cell 
(Fig.  1 c). There were also small and large granulomas con- 
sisting of extensive centrally located necrotic, calcified mate- 
rial and a fibrous capsule containing macrophages and lym- 
phocytes. These lesions were mostly located in the walls of 
large veins, and their morphology was similar to fibrocalcific 
tuberculosis (Fig.  l f).  The granulomatous liver lesions in 
Bacillus Calmette-Gu6rin Infection in Mice Lacking IFN-~/Receptor Table  1.  Granulomatous  Lesions and Acidfast  Bacteria in Liver Sections from BCG-infected Mice 
Time after  Group  Area occupied by 
inoculation  of mice  granulomas 
No.  of acid-fast rods/microscopic field 
0  1-10  >10 
wk  %  +  SEM  No.  of  fields 
2  Wild-type  24.9  •  2.1"  1'  29  30 
IFN-'yR  ~176  8.8  •  1.7  0  13  47 
6  Wild-type  9.3  •  3.8  12  40  8 
IFN-3/R  ~176  11.5  •  1.1  1  24  35 
" Percent area occupied by granulomatous lesions was determined by examining randomly selected microscopic fields of 310,000-330,000  #m  2 each 
in liver sections of three mice/group with the aid of a computerized  digitizing tablet and Bioquant IV software (K&M Biometrics, Nashville, TN). 
20 fields/animal  were evaluated.  The difference between wild-type and IFN-3,K  ~  mice was statistically significant at 2 (p  =  0.0238) but not at 
6 wk (p  ~  0.7356),  as determined by two-sided  t-test. 
* Sections of livers from three mice were examined in each group. Acid-fast rods were counted in 20 randomly selected microscopic fields/mouse. 
The total number of fields containing 0,  1-10, or >10 acid-fast rods per field is shown for each group of mice. The difference between wild-type 
and IFN-3,R  0/0 mice was statistically significant at 2 (p  =  0.0049)  and at 6 wk (p <  0.0001),  as determined by two-sided  2  x  3 X 2 test. 
Figure  1.  BCG-induced gran- 
ulomas in wild-type (a and b) and 
IFN-'/R  0/~ mice (c and d) at  2 
wk (a and c) and 6 wk (b and d) 
after infection (H&E,  x240). The 
granulomas shown here are typ- 
ical examples of the lesions found 
in the two types of mice at the 
two time points (see Results). (e) 
Characteristic rod-shaped  MFobac- 
ter~ in a granuloma  from an IFN- 
"yR  0/0 mouse at 2 wk after inocu- 
lation, mostly  localized within 
macrophages (Ziehl-Neelsen stain 
with  Light  green counterstain, 
x 950). (f) A fibrocalcific  granu- 
loma found in a wild-type mouse 
6  wk  after  infection  (H&E, 
x 120). 
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Survival curve of BCC-L,K~ed mice after LPS d~enge. Wild- 
type (n  =  8) and IFN-?K  ~176  (n  ~  7) mice were inoculated in the tail 
vein with BCG (2  x  107 bacteria/mouse).  At 2 wk after inoculation, 
LPS (25 #g/mouse) was injected intravenously. Survival was checked at 
regular intervals for 72 h. 
IFN-3,R  ~176  mice infected with BCG 6 wk earlier consisted 
of a central zone with variable necrosis, epithdioid cells, and 
some polymorphonudear cells, and a more cellular periphery 
containing macrophages, lymphocytes, neutrophils,  eosino- 
phils, and some fibroblasts; there were no Langerhans cells 
or fibrocalcified granulomas (Fig.  1 d). 
Reduced Lethality of Endotoxin in BCG-infected IFN-TR ~176 
Mice.  Infection of mice or other laboratory animals with 
BCG leads to a greatly increased sensitivity to the lethal ac- 
tion of LPS. Mice infected with BCG are killed by an intra- 
venous injection of ,'~100 times less LPS than is required to 
kill normal mice (7). To determine whether IFN-3, is required 
for the development of hyperreactivity to LPS, wild-type and 
IFN-3,R ~176  mice were injected intravenously with 25/~g LPS 
2 wk after inoculation with BCG. By 24 h, six out of eight 
wild-type mice had died,  whereas none of the IFN-q,R  ~176 
mice died within this time period (Fig. 2). One out of seven 
IFN-3,K  ~176  mice died at 41 h after LPS injection. The differ- 
ence in the overall survival rate between the two groups of 
mice is statistically significant (p  =  0.0317, as determined 
by one-sided Fisher's exact test). 
Large Increase in the Production of TNF~ and other Cytokines, 
Seen in BeG-infected Wild-type Mice after Challenge with LPS, 
Is  Abrogated in  IFN-TR ~176  Mice.  Injection  of LPS  into 
BCG-infected mice leads to a rapid production of high levels 
of TNF-o~ and other cytokines (4-6). In view of the known 
role of TNF-c~ as a mediator of LPS toxicity (22), it seemed 
likely that a decreased production of TNF-c~ might underlie 
the markedly reduced lethal effect of LPS in BCG-infected 
IFN-'yR  ~176  mice.  To analyze cytokine production, we in- 
jected LPS intravenously into both wild-type and IFN-3'R  ~176 
mice, 2 wk after their inoculation with BCG.  The serum 
levels of TNF-a, IL-lo~, and IL-6 were determined in these 
mice 2 h after LPS injection (Fig. 3). In paralld, serum levels 
of these cytokines were determined 2 h after LPS injection 
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Figure 3.  Cytokine levels  in the serum of BCG-infected and uninfected 
mice after LPS challenge. Wild-type and IFN-?R  0/0 mice (n =  7/group) 
were inoculated in the tail vein with BCG (2  x  107 bacteria/mouse).  At 
2 wk after inoculation, LPS (25/~g/mouse) was injected intravenously 
(n =  4/group). The rest of the BCG-infected mice (n  =  3/group) were 
not injected with LPS. Uninfected mice (n =  3/group) were also injected 
with same dose of LPS. Mice were bled 2 h after LPS injection, and serum 
cytokine levels were measured by ELISA. (Error bars) SD; (numbers, top) 
exact cytokine level, in ng/ml (TN/~c~ and IL6) or pg/ml (/bla). 
in mice not infected with BCG.  Cytokine levels were also 
measured in the serum of mice that were inoculated with 
BCG 2 wk earlier, but not challenged with LPS. In wild- 
type mice, injection of LPS in BCG-infected  animals pro- 
duced a dramatic increase in the serum levels of TNF-o~, with 
the concentration of this cytokine reaching levels that were 
about 75-fold higher than in mice injected with BCG alone 
and over 200 times higher than in uninfected LPS-injected 
mice. This large increase in TNP-ol production seen in LPS- 
challenged, BCG-infected mice was completdy abrogated in 
the  IFN-3,K ~176  mice.  Although  the  increase  in  IL-lo~ 
production elicited by LPS in BCG-infected wild-type mice 
was somewhat less dramatic (about 25-fold) than the corre- 
sponding increase in TNP-a levels, this stimulation too was 
not  seen  in  the  IFN-'yR  ~176  mice.  The  increase in  LPS- 
induced IL-6 production in BCG-inoculated mice, compared 
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type mice, but this stimulation also was largely absent in the 
IFN-3~R  ~176  mice. 
Discussion 
Our results have dearly established the critical role of the 
IFN-'I, receptor in the ability of normal mice to contain in- 
fection with the BCG strain of M.  bov/s. IFN-'I/R  ~176  mice 
showed decreased granuloma formation in the livers at 2 wk 
after inoculation and a reduced ability to diminate mycobac- 
teria from the liver (Table 1). All IFN-q,R  ~176  mice died be- 
tween 49 and 65 d after BCG inoculation, whereas all wild- 
type animals survived the infection. A similar nearly 100% 
mortality after BCG inoculation was recently reported by 
Dalton et al. (21) in mice with a targeted deletion of the struc- 
tural gene for IFN-% Earlier, Kindler et al. (11) revealed an 
essential  role for TNF-c~ in resistance  to BCG by demon- 
strating that the administration of Abs to murine TNF-ot 
converted the normally nonlethal self-limiting BCG infec- 
tion in mice into a fulminant, progressive infection. The latter 
authors concluded that TNF-c~ promotes the formation of 
bactericidal granulomas that are abundant in the liver and 
other organs of mice at 2-3 wk after BCG inoculation. In- 
terestingly, our studies revealed  a similar role for IFN-3,. Hence, 
recovery of mice from BCG infection apparently requires both 
IFN-3, and TNF-ot. 
It is well known that (a) IFN-3, promotes TNF-c~ syn- 
thesis by murine macrophages (23), and (b) IFN-3' and TNF-ot 
act synergistically  to induce microbicidal activity and nitric 
oxide release in macrophages (19, 24, 25). Both of these types 
of interactions between IFN-3' and TNF-ot are likely to be 
important in the murine BCG infection. The serum of BCG- 
infected IFN-q,R  ~176  mice contained 100 times less TNF-or 
at 2 h after LPS challenge than the serum of identically treated 
wild-type mice (Fig. 3). TNF-ce levels in the serum at 2 h 
after LPS challenge are likely to reflect mainly the release of 
TNF-ot from preexisting stores, rather than its de novo syn- 
thesis.  This conclusion is supported by the high levels of 
TNF-c~ mRNA and of immunoreactive  TNF-cr protein found 
in the granulomatous liver tissue of mice 2 and 3 wk after 
BCG infection (11). Yet, without a LPS challenge, TNF-cr 
levels in the serum were low (Fig.  3), which is consistent 
with the earlier conclusion that TNF-ot mRNA and protein 
accumulate within the disseminated granulomas in the organs, 
but little or no release of TNF-c~ protein takes place (11). 
Hence, in the IFN-3,R  ~176  mice synthesis of TNF-c~ within 
the granulomas is likely to be severely impaired. Interestingly, 
although the area occupied by granulomas in the liver sec- 
tions was about two-thirds less in IFN-3,K  0/~ mice than in 
wild-type mice at 2 wk after BCG infection (Table 1), granu- 
loma formation was not completely suppressed.  However, 
the granulomas in IFN-3~R  ~176  mice at 2 wk appeared to con- 
tain fewer epithelioid cells, perhaps reflecting an impairment 
in the process of macrophage differentiation into cells that 
are capable of killing ingested mycobacteria.  Kindler et al. 
(11) concluded that TNF-ot is indispensable  for the process 
of granuloma formation required to contain bacterial dissemi- 
nation. The likewise indispensable role of IFN-3~ then might 
be explained solely on the basis of the absolute requirement 
of IFN-3, for the generation of TNF-c~ in the BCG-infected 
animals demonstrated in this study. However, it is likely that 
IFN-y would also be necessary to act synergistically  with 
TNF-ot in promoting the formation of fully functional bac- 
tericidal  granulomas (19, 24, 25).  Our results  also demon- 
strate the essential role of IFN-3~ in the production of high 
serum levels of IL-lot and IL-6 characteristic of BCG-infected 
mice challenged with LPS (Fig. 3). Failure to produce high 
levels of IL-1 could contribute to the decreased lethality of 
LPS in BCG-infected IFN-3tR  ~176  mice. 
Our finding that BCG-infected IFN-TR  ~176  mice fail to 
produce high cytokine levels in response to LPS (Fig. 3) is 
related  to the recent demonstration that administration of 
Abs to IFN-3' to mice infected with Listeria monocytogenes 
blocked the production of high levels of TNF and IFN-oJ~/ 
elicited in these mice by LPS injection (26). The demonstra- 
tion that IFN-3,R  ~176  mice were more resistant  to the lethal 
effect of LPS at 2 wk after BCG inoculation than wild-type 
mice (Fig. 2) is reminiscent of two other experimental mu- 
rine models in which TNF-mediated lethal toxicity could 
be blocked by antibodies to IFN-% One such model is the 
LPS-induced Shwartzman-like shock in which mAbs to IFN-~/ 
were shown both to reduce mortality and decrease serum TNF 
levels (27). Another model is experimental murine cerebral 
malaria,  a lethal neurological syndrome that develops in ge- 
netically susceptible mice after injection with Plasmodium ber- 
ghei, accompanied by the appearance of high levels of TNF 
in the serum (28, 29). Mice could be protected from cerebral 
malaria  not only by Abs to TNF-ot (28),  but also by Abs 
to IFN-'y (29). Moreover, the protective effect of Abs to IFN-3, 
was accompanied by a marked reduction in serum TNF levels. 
The use of IFN-~/R  ~176  mice (20) or of mice with a targeted 
deletion of the structural gene for IFN-3, (21) should greatly 
facilitate  defining the roles of IFN-3~ in cytokine cascades 
during the pathogenesis of many other types of disorders. 
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